Evidence map›Paper›PMID 39234228›Full record

ArticleIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine2024

ISCCM Position Statement on the Management of Invasive Fungal Infections in the Intensive Care Unit.

Pradip Kumar Bhattacharya, Arunaloke Chakrabarti, Saswati Sinha, Rajesh Pande, Sachin Gupta, Ak Ajith Kumar, Vijay Kumar Mishra, Sanjeev Kumar, Shilpushp Bhosale, Pavan Kumar Reddy

Abstract read
In one paragraph

Article in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Can We Have Guidelines or Just Guidance for Rare Fungal Infections?Journal of fungi (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pradip Kumar BhattacharyaDepartment of Critical Care Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.ORCID https://orcid.org/0000-0002-0219-385X
Arunaloke ChakrabartiDepartment of Medical Microbiology, Doodhadhari Burfani Hospital, Haridwar, Uttarakhand, India.ORCID https://orcid.org/0000-0003-1555-3807
Saswati SinhaDepartment of Critical Care, Manipal Hospitals, Kolkata, West Bengal, India.ORCID https://orcid.org/0009-0008-9954-8514
Rajesh PandeDepartment of Critical Care, BLK MAX Superspeciality Hospital, Delhi, India.ORCID https://orcid.org/0000-0002-0149-727X
Sachin GuptaDepartment of Critical Care, Narayana Superspeciality Hospital, Gurugram, Haryana, India.ORCID https://orcid.org/0000-0001-8663-9507
Ak Ajith KumarDepartment of Critical Care Medicine, Aster Whitefield Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0001-5134-1698
Vijay Kumar MishraDepartment of Critical Care, Bhagwan Mahavir Medica Superspecialty Hospital, Ranchi, Jharkhand, India.ORCID https://orcid.org/0000-0002-4872-6244
Sanjeev KumarDepartment of Anaesthesiology and Critical Care Medicine, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.ORCID https://orcid.org/0000-0001-5055-9126
Shilpushp BhosaleDepartment of Critical Care Medicine, ACTREC, Tata Memorial Centre, HBNI, Mumbai, Maharashtra, India.ORCID https://orcid.org/0000-0002-0290-0526
Pavan Kumar ReddyDepartment of Critical Care Medicine, ARETE Hospitals, Hyderabad, Telangana, India.ORCID https://orcid.org/0000-0002-2896-1810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale: Invasive fungal infections (IFI) in the intensive care unit (ICU) are an emerging problem owing to the use of broad-spectrum antibiotics, immunosuppressive agents, and frequency of indwelling catheters. Timely diagnosis which is imperative to improve outcomes can be challenging. This position statement is aimed at understanding risk factors, providing a rational diagnostic approach, and guiding clinicians to optimize antifungal therapy. Objectives: To update evidence on epidemiology, risk factors, diagnostic approach, antifungal initiation strategy, therapeutic interventions including site-specific infections and role of therapeutic drug monitoring in IFI in ICU and focus on some practice points relevant to these domains. Methodology: A committee comprising critical care specialists across the country was formed and specific aspects of fungal infections and antifungal treatment were assigned to each member. They extensively reviewed the literature including the electronic databases and the international guidelines and cross-references. The information was shared and discussed over several meetings and position statements were framed to ensure their reliability and relevance in critical practice. The draft document was prepared after obtaining inputs and consensus from all the members and was reviewed by an expert in this field. Results: The existing evidence on the management of IFI was updated and practice points were prepared under each subheading to enable critical care practitioners to streamline diagnosis and treatment strategies for patients in the ICU with additional detail on site-specific infections therapeutic drug monitoring. Conclusion: This position statement attempts to address the management of IFI in immunocompetent and non-neutropenic ICU patients. The practice points should guide in optimization of the management of critically ill patients with suspected or proven fungal infections. How to cite this article: Bhattacharya PK, Chakrabarti A, Sinha S, Pande R, Gupta S, Kumar AAK,

Indexed as

Antifungal susceptibilityAntifungal therapyCryptococcusHistoplasmosisIntensive care unitInvasive aspergillosisInvasive candidiasisInvasive fungal infectionsMucormycosis

Identifiers

PMID39234228
PMCPMC11369924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.